| Exosomal lncRNA-MIAT promotes neovascularization via the miR-133a-3p/MMP-X1 axis in diabetic retinopathy. | Exosomal lncRNA-MIAT promotes neovascularization via the miR-133a-3p/MMP-X1 axis in diabetic retinopathy.
Li X, Cao Q, Xu C, Wang J, Pan T, Liu Q, Xie P, Hu Z. | 05/28/2024 |
| Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy. | Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy.
Liu B, Wei Y, He J, Feng B, Chen Y, Guo R, Griffin MD, Hynes SO, Shen S, Liu Y, Cui H, Ma J, O'Brien T., Free PMC Article | 04/29/2024 |
| MicroRNA-133a-3p Inhibits Lung Adenocarcinoma Development and Cisplatin Resistance through Targeting GINS4. | MicroRNA-133a-3p Inhibits Lung Adenocarcinoma Development and Cisplatin Resistance through Targeting GINS4.
Zhou Y, Yan J, Chen H, Zhou W, Yang J. | 02/22/2024 |
| The role of miR1 and miR133a in new-onset atrial fibrillation after acute myocardial infarction. | The role of miR1 and miR133a in new-onset atrial fibrillation after acute myocardial infarction.
Zeng Q, Li W, Luo Z, Zhou H, Duan Z, Xiong XL., Free PMC Article | 09/28/2023 |
| Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner. | Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.
Zhang CP, Huang XY. | 08/25/2023 |
| Investigation of miR-133a, miR-637 and miR-944 genes expression and their relationship with PI3K/AKT signaling in women with breast cancer. | Investigation of miR-133a, miR-637 and miR-944 genes expression and their relationship with PI3K/AKT signaling in women with breast cancer.
Barartabar Z, Moini N, Abbasalipourkabir R, Mesbah-Namin SA, Ziamajidi N. | 07/27/2023 |
| DNA methylation-induced ablation of miR-133a accelerates cancer aggressiveness in glioma through upregulating peroxisome proliferator-activated receptor gamma. | DNA methylation-induced ablation of miR-133a accelerates cancer aggressiveness in glioma through upregulating peroxisome proliferator-activated receptor γ.
Liu L, Zhu Z, Li X, Zheng Y. | 02/4/2023 |
| Up-regulation of miR-133a-3p promotes ovary insulin resistance on granulosa cells of obese PCOS patients via inhibiting PI3K/AKT signaling. | Up-regulation of miR-133a-3p promotes ovary insulin resistance on granulosa cells of obese PCOS patients via inhibiting PI3K/AKT signaling.
Yang X, Wang K, Lang J, Guo D, Gao H, Qiu Y, Jin X, Zhang M, Shi J, Ma Q, Ma Q, Wen Z., Free PMC Article | 10/15/2022 |
| Circ-NCX1 inhibits LPS-induced chondrocyte apoptosis by regulating the miR-133a/SIRT1 axis. | Circ-NCX1 inhibits LPS-induced chondrocyte apoptosis by regulating the miR-133a/SIRT1 axis.
Liu K, Fan XE, Zhang L, Yang Y, Zhou XL. | 10/15/2022 |
| Aberrant expression of miR-133a in endothelial cells inhibits angiogenesis by reducing pro-angiogenic but increasing anti-angiogenic gene expression. | Aberrant expression of miR-133a in endothelial cells inhibits angiogenesis by reducing pro-angiogenic but increasing anti-angiogenic gene expression.
Ahmed S, Kurusamy S, David ELS, Khan K, Kalyanakrishnan K, Ian-Gobo M, Kola TM, Wilkinson RN, Kannappan V, Wang W, Gómez MJ, Redondo JM, Cotton J, Armesilla AL., Free PMC Article | 09/17/2022 |
| Circulating microRNA-27a and -133a are negatively associated with incident hypertension: a five-year longitudinal population-based study. | Circulating microRNA-27a and -133a are negatively associated with incident hypertension: a five-year longitudinal population-based study.
Suzuki K, Yamada H, Fujii R, Munetsuna E, Yamazaki M, Ando Y, Ohashi K, Ishikawa H, Mizuno G, Tsuboi Y, Hashimoto S, Hamajima N. | 07/23/2022 |
| The Expression and Role of microRNA-133a in Plasma of Patients with Kawasaki Disease. | The Expression and Role of microRNA-133a in Plasma of Patients with Kawasaki Disease.
Luo Y, Yu M, Li P, Huang L, Wu J, Kong M, Li Y, Wu Z, Kang Z, Yi L, Yang Z. | 06/11/2022 |
| MiR-133a-3p attenuates resistance of non-small cell lung cancer cells to gefitinib by targeting SPAG5. | MiR-133a-3p attenuates resistance of non-small cell lung cancer cells to gefitinib by targeting SPAG5.
Li Q, Wang Y, He J., Free PMC Article | 12/25/2021 |
| MiR-133a acts as a tumor suppressor in lung cancer progression by regulating the LASP1 and TGF-beta/Smad3 signaling pathway. | MiR-133a acts as a tumor suppressor in lung cancer progression by regulating the LASP1 and TGF-β/Smad3 signaling pathway.
Shen Y, Yang Y, Li Y., Free PMC Article | 11/22/2021 |
| Long Non-coding RNA LINC01503 Promotes Gastric Cardia Adenocarcinoma Progression via miR-133a-5p/VIM Axis and EMT Process. | Long Non-coding RNA LINC01503 Promotes Gastric Cardia Adenocarcinoma Progression via miR-133a-5p/VIM Axis and EMT Process.
Guo Y, Sun P, Guo W, Dong Z. | 11/13/2021 |
| The miR-133a, TPM4 and TAp63gamma Role in Myocyte Differentiation Microfilament Remodelling and Colon Cancer Progression. | The miR-133a, TPM4 and TAp63γ Role in Myocyte Differentiation Microfilament Remodelling and Colon Cancer Progression.
Caporali S, Calabrese C, Minieri M, Pieri M, Tarantino U, Marini M, D'Ottavio S, Angeletti S, Mauriello A, Cortese C, Bernardini S, Terrinoni A., Free PMC Article | 10/23/2021 |
| High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients. | High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients.
Escate R, Padró T, Suades R, Camino S, Muñiz O, Diaz-Diaz JL, Sionis A, Mata P, Badimon L. | 10/9/2021 |
| Regulator of G-protein signalling 3 and its regulator microRNA-133a mediate cell proliferation in gastric cancer. | Regulator of G-protein signalling 3 and its regulator microRNA-133a mediate cell proliferation in gastric cancer.
Li W, Si X, Yang J, Zhang J, Yu K, Cao Y. | 09/11/2021 |
| MicroRNA-133a Regulates the Viability and Differentiation Fate of Bone Marrow Mesenchymal Stem Cells via MAPK/ERK Signaling Pathway by Targeting FGFR1. | MicroRNA-133a Regulates the Viability and Differentiation Fate of Bone Marrow Mesenchymal Stem Cells via MAPK/ERK Signaling Pathway by Targeting FGFR1.
Wang G, Wan L, Zhang L, Yan C, Zhang Y. | 08/14/2021 |
| LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway. | LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway.
Xu L, Xu Y, Yang M, Li J, Xu F, Chen BL., Free PMC Article | 07/17/2021 |
| miR-133a-3p/FOXP3 axis regulates cell proliferation and autophagy in gastric cancer. | miR-133a-3p/FOXP3 axis regulates cell proliferation and autophagy in gastric cancer.
Li JP, Zhang HM, Liu MJ, Xiang Y, Li H, Huang F, Li HH, Dai ZT, Gu CJ, Liao XH, Zhang TC. | 07/10/2021 |
| Overexpression of miR-133a-3p inhibits fibrosis and proliferation of keloid fibroblasts by regulating IRF5 to inhibit the TGF-beta/Smad2 pathway. | Overexpression of miR-133a-3p inhibits fibrosis and proliferation of keloid fibroblasts by regulating IRF5 to inhibit the TGF-β/Smad2 pathway.
Huang Y, Wang Y, Lin L, Wang P, Jiang L, Liu J, Wang X. | 06/5/2021 |
| UCP2, IL18, and miR-133a-3p are dysregulated in subcutaneous adipose tissue of patients with obesity. | UCP2, IL18, and miR-133a-3p are dysregulated in subcutaneous adipose tissue of patients with obesity.
Oliveira MS, Rheinheimer J, Moehlecke M, Rodrigues M, Assmann TS, Leitão CB, Trindade MRM, Crispim D, de Souza BM. | 05/29/2021 |
| Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis. | Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis.
Yang H, Zhang H, Yang Y, Wang X, Deng T, Liu R, Ning T, Bai M, Li H, Zhu K, Li J, Fan Q, Ying G, Ba Y., Free PMC Article | 05/8/2021 |
| MicroRNA-133a-5p inhibiting metastatic capacity of renal clear cell carcinoma through regulating MON2. | MicroRNA-133a-5p inhibiting metastatic capacity of renal clear cell carcinoma through regulating MON2.
Li P, Wu Q, Yang XR, Sun T. | 04/24/2021 |